News
GlaxoSmithKline plc (UK) (($GB:GSK)) announced an update on their ongoing clinical study. GlaxoSmithKline (GSK) is ...
5d
TipRanks on MSNGSK’s Promising Study on Belimumab for Systemic Sclerosis Lung Disease
GlaxoSmithKline plc (UK) (($GB:GSK)) announced an update on their ongoing clinical study. GlaxoSmithKline (GSK) is ...
Use of belimumab prior to vs after initiating immunosuppressants was linked to faster OGC tapering and fewer disease flares among patients with SLE.
Although obinutuzumab has not yet received FDA approval in lupus nephritis, findings from a recent survey conducted by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results